- Home
- YRD vs INMB Comparison
YRD vs INMB Comparison
Compare YRD & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YRD | INMB |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.5M | 64.7M |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | YRD | INMB |
|---|---|---|
| Price | $0.36 | $1.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 2.4M | 254.7K |
| Earning Date | 11-24-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | $425.24 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.86 | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $0.36 | $1.09 |
| 52 Week High | $5.60 | $2.60 |
Technical Indicators
Market Signals| Indicator | YRD | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 26.97 | 24.75 |
| Support Level | $0.36 | N/A |
| Resistance Level | $1.05 | $1.52 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 1.10 | 10.76 |
Price Performance
Historical ComparisonAbout YRD Yiren Digital Ltd.
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.